ZIM Laboratories Limited (NSE:ZIMLAB)

Market Cap	5.57B
Revenue (ttm)	3.79B
Net Income (ttm)	121.65M
Shares Out	n/a
EPS (ttm)	2.50
PE Ratio	45.78
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	26,394
Average Volume	81,354
Open	114.40
Previous Close	114.41
Day's Range	113.31 - 116.01
52-Week Range	79.49 - 128.90
Beta	0.50
RSI	64.32
Earnings Date	Aug 8, 2025

About ZIM Laboratories

ZIM Laboratories Limited engages in the development, manufacture, and supply of generic pharmaceutical and nutraceutical products in India and internationally. It provides its products in pre- formulation intermediates and finished formulations in the oral solid dosage forms, such as pellets, taste-masked powders, granules, tablets, capsules, dry syrup, and oral thin films. The company offers therapeutics in the areas of urology, gastroenterology, antibiotics, anti-infectives, cardiovascular, central nervous system, NSAIDs/pain analgesics, and ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1984
• Employees: 577
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: ZIMLAB

Financial Performance

In 2024, ZIM Laboratories's revenue was 3.79 billion, an increase of 3.16% compared to the previous year's 3.68 billion. Earnings were 121.65 million, a decrease of -29.46%.